Q3 2017 Holdings
Filed 2017-11-14 | 37 holdings | $68.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $40.5M | 2,230,898 | 59.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $18.0M | 1,241,021 | 26.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $7.3M | 459,396 | 10.8% |
| Anthera Pharmaceuticals Inc(ANTH) | COM | 03674U300 | $1.4M | 1,006,507 | 2.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $78.8K | 6,402,525 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $70.2K | 1,007,354 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $56.3K | 7,587,416 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $48.2K | 1,379,134 | 0.1% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $46.2K | 3,135,289 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $45.2K | 3,229,856 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $44.5K | 2,820,000 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $29.5K | 1,502,800 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $29.1K | 25,995,575 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $27.4K | 8,596,357 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $22.0K | 238,386 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $20.2K | 1,353,846 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $19.9K | $4,400,289 | 0.0% |
| Zealand Pharma A S | SPONSORED ADR | 98920Y304 | $19.2K | 1,000,000 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $17.2K | 2,986,562 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $16.2K | 12,949,229 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $15.0K | 950,000 | 0.0% |
| Tocagen Inc | COM | 888846102 | $13.2K | 1,063,028 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $12.8K | 3,133,224 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $11.0K | 652,676 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.6K | 3,588,830 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $10.5K | 7,866,108 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $9.1K | 1,108,433 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $8.6K | 1,455,117 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $8.2K | 7,400,128 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.8K | 675,759 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $5.0K | 724,132 | 0.0% |
| Orexigen Therapeutics Inc | NOTE 2.750%12/0 | 686164AB0 | $4.8K | 10,000,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $4.0K | 2,043,196 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $3.9K | 3,500,000 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $2.0K | 184,764 | 0.0% |
| Orexigen Therapeutics Inc | COM NEW | 686164302 | $1.6K | 734,976 | 0.0% |
| Pain Therapeutics Inc | COM NEW | 69562K506 | $1.3K | 325,508 | 0.0% |